[go: up one dir, main page]

WO1991017187A3 - ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION - Google Patents

ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION

Info

Publication number
WO1991017187A3
WO1991017187A3 PCT/US1991/002638 US9102638W WO9117187A3 WO 1991017187 A3 WO1991017187 A3 WO 1991017187A3 US 9102638 W US9102638 W US 9102638W WO 9117187 A3 WO9117187 A3 WO 9117187A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumor associated
detection
methods
associated protein
protein antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1991/002638
Other languages
English (en)
Other versions
WO1991017187A2 (fr
Inventor
Jan H Wong
Rishab K Gupta
Donald L Morton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to JP91508637A priority Critical patent/JPH05506241A/ja
Publication of WO1991017187A2 publication Critical patent/WO1991017187A2/fr
Publication of WO1991017187A3 publication Critical patent/WO1991017187A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Isolation et caractérisation d'un antigène associé à une tumeur, lequel peut être utilisé dans l'immunodiagnostic, l'immunopronostic, et la thérapie du cancer chez l'homme. L'antigène est une molécule protéique d'une masse moléculaire d'environ 35 kD après réduction et séparation par électrophorèse sur gel de SDS-polyacrylamine. On a détecté l'antigène dans du sérum prélevé sur des patients atteints d'un cancer.
PCT/US1991/002638 1990-04-18 1991-04-17 ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION Ceased WO1991017187A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP91508637A JPH05506241A (ja) 1990-04-18 1991-04-17 ３５ｋｄ腫瘍関連タンパク質抗原および免疫複合体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51060290A 1990-04-18 1990-04-18
US510,602 1990-04-18

Publications (2)

Publication Number Publication Date
WO1991017187A2 WO1991017187A2 (fr) 1991-11-14
WO1991017187A3 true WO1991017187A3 (fr) 1991-12-26

Family

ID=24031404

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/002638 Ceased WO1991017187A2 (fr) 1990-04-18 1991-04-17 ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION

Country Status (5)

Country Link
US (2) US6491926B1 (fr)
EP (1) EP0529007A1 (fr)
JP (1) JPH05506241A (fr)
CA (1) CA2080835A1 (fr)
WO (1) WO1991017187A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0529007A1 (fr) 1990-04-18 1993-03-03 The Regents Of The University Of California ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION
US5997869A (en) * 1993-03-15 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens
AU2003218049A1 (en) * 2002-02-27 2003-09-09 University Of South Carolina Targeted immunotherapy of acute lymphoblastic leukemia (all)
ITPD20030264A1 (it) 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
GB0408164D0 (en) * 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133543A (en) * 1982-11-16 1984-07-25 Masaru Taniguchi Monoclonal antibody specific to human melanoma
WO1989000050A1 (fr) * 1987-07-02 1989-01-12 Akzo N.V. Antigene identifie par mca 16-88
US4806628A (en) * 1982-11-30 1989-02-21 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies against melanocytes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851510A (en) 1984-11-30 1989-07-25 Wadley Technologies, Inc. Monoclonal antibodies to novel melanoma-associated antigens
US4879225A (en) 1986-06-20 1989-11-07 Neorx Corporation Enhanced production of antibodies utilizing insolubilized immune complexes
EP0529007A1 (fr) 1990-04-18 1993-03-03 The Regents Of The University Of California ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133543A (en) * 1982-11-16 1984-07-25 Masaru Taniguchi Monoclonal antibody specific to human melanoma
US4806628A (en) * 1982-11-30 1989-02-21 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies against melanocytes
WO1989000050A1 (fr) * 1987-07-02 1989-01-12 Akzo N.V. Antigene identifie par mca 16-88

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Br. J. Cancer, Vol. 55, 1987 Kellokumpu I et al.: "Identification of glycoproteins expressing tumor-associated PNA-binding sites in colorectal carcinomas by SDS-GEL electrophoresis and PNA-labelling ", *
Cancer Research, Vol. 46, October 1986 B Drewinko et al.: "New Monoclonal Antibodies against Colon Cancer-associated Antigens ", *
Dialog Information Services, File 159, Cancerlit, accession no. 00365788, Paulie S et al: "Lectins as probes for identification of tumor-associated anti- gens on urothelial and colonic carcinoma cell lines"& Int J Cancer; 31(3):297-303 1983 *
Dialog Information Services, File 159, Cancerlit, accession no. 00678087, Xiang JH et al: "Synthesis and expression of metastasis-associated, MET-72/83 antigens", & Clin Exp Metastasis; 6(6):473-83 1988 *
Dialog Information Services, File 72, EMBASE, accession no. 6411631, Kellokumpu I et al: "Identi- fication of glycoproteins expressing tumor-associ- ated PNA-binding sites in colorectal carcinomas by SDS-gel electrophoresis and PNA-labelling", & BR. J.CANCER (UK), 1987, 55/4 (361-365) *
Int. J. Cancer, Vol. 45, March 1990 Wong J H et al.: "Detection and isolation of antigen-specific immune complexesfrom sera of melanoma patients ", *
Journal of Surgical Oncology, Vol. 38, 1988 Wong J H et al.: "Demonstration of a Well-Characterized Tumor-Associated Antigen on Melanoma Cell Surface ", *
Journal of Surgical Research, Vol. 48, June 1990 J H Wong et al.: "Immunochemical Characterization of a Tumor-Associated Antigen Defined by a Monoclonal Antibody. ", *
National Library of Medicine (NLM), File cancerlit, accession no medl/90147003, Wong JH et al: "Tumor- associated antigen immune complexes. A potential marker of recurrent melanoma", & Arch Surg; 125(2): 187-91 1990 *

Also Published As

Publication number Publication date
WO1991017187A2 (fr) 1991-11-14
US7097846B2 (en) 2006-08-29
CA2080835A1 (fr) 1991-10-19
JPH05506241A (ja) 1993-09-16
US20030064065A1 (en) 2003-04-03
EP0529007A1 (fr) 1993-03-03
US6491926B1 (en) 2002-12-10

Similar Documents

Publication Publication Date Title
Linke et al. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
NO913211D0 (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
NO985150L (no) Antigenbindingsfragmenter som spesifikt detekterer cancerceller, nukleotider som koder fragmentene samt anvendelse derav for profylakse og deteksjon av cancere
WO1998008542A3 (fr) Composes et procedes destines au traitement et au diagnostic d'infections mycobacteriennes
DE69333802T8 (de) Äusseres membranprotein von haemophilus
WO2001040269A3 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
WO2000060076A3 (fr) Compositions pour le traitement et le diagnostic du cancer du sein et leurs procedes d'utilisation
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
WO2000060077A3 (fr) Composes utilises dans la therapie et le diagnostic du cancer du poumon et methodes d'utilisation
AU3125289A (en) Monoclonal antibodies directed against human tumor necrosis factor - receptor
WO2000037643A3 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
GB2186885B (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas
NO871352L (no) Fremgangsmaater og blandinger for identifikasjon av metastatiske mennesketumorer.
WO2001018046A3 (fr) Sequences de tumeurs ovariennes et procedes d'utilisation correspondants
WO1991017187A3 (fr) ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION
EP0369816A3 (fr) Anticorps monoclonaux spécifiques pour la mucine polymorphe épithéliale humaine
WO2000078960A3 (fr) Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
ES2012997A6 (es) Un procedimiento para la obtencion de una linea de celulas hibridas que producen un anticuerpo monoclonal.
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
WO2001021653A3 (fr) Antigene de tumeur ovarienne et techniques d'utilisation de celui-ci
AU5752490A (en) A novel tumor associated antigen
WO1997035884A8 (fr) Production amelioree d'anticorps par l'utilisation de complexes antigene-anticorps
WO1999054466A3 (fr) Antigenes associes au cancer du colon, et utilisations desdits antigenes a des fins diagnostiques ou therapeutiques
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT BB BG BR CA FI HU JP KP KR LK MC MG MW NO PL RO SD SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT BB BG BR CA FI HU JP KP KR LK MC MG MW NO PL RO SD SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: REVISED TITLE AND ABSTRACT RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION

WWE Wipo information: entry into national phase

Ref document number: 2080835

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991920948

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991920948

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991920948

Country of ref document: EP